Data / Form D filings / Vergent Bioscience, Inc.
Vergent Bioscience, Inc.: Form D filings
Vergent Bioscience, Inc., a biotechnology company in Minneapolis, MN, filed 8 Form D notices with the SEC between 2018 and 2025. The latest, on October 20, 2025, reports $18.7 million sold of a $32 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5810 W 78TH ST, STE 222, Minneapolis, MN, 55439
- Phone
- (952) 426-3772
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1741495
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | New notice | $31,957,273 | $18,673,277 | $13,283,996 | 20 | Oct 7, 2025 | sec.gov |
| Feb 18, 2025 | Amendment | $5,000,000 | $3,750,000 | $1,250,000 | 5 | Feb 3, 2025 | sec.gov |
| Feb 18, 2025 | New notice | $5,000,000 | $3,750,000 | $1,250,000 | 5 | Feb 3, 2025 | sec.gov |
| Oct 4, 2022 | New notice | $22,090,063 | $21,542,628 | $547,435 | 27 | Aug 17, 2022 | sec.gov |
| Nov 22, 2021 | New notice | $2,000,000 | $1,163,814 | $836,186 | 16 | Nov 8, 2021 | sec.gov |
| Sep 23, 2020 | Amendment | $11,916,407 | $11,916,407 | 21 | May 18, 2018 | sec.gov | |
| Feb 22, 2019 | Amendment | $9,680,613 | $9,680,613 | 19 | May 18, 2018 | sec.gov | |
| Jun 1, 2018 | New notice | $8,680,613 | $8,680,613 | 14 | May 18, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bobby T. Helmedag | Director | |
| Jeffrey T. Yurecko | Executive Officer | |
| Anita T. Watkins | Director | |
| John T. Santini, Jr. | Executive Officer, Director | |
| Raymond T. Wong | Director | |
| Douglas T. Kohrs | Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vergent Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.